BDBM593054 2-methyl-2-(3-methyl-4-((4- (((1R,4R)-4- (methylamino)cyclohexyl)methoxy) pyrimidin-2-yl)amino)-1H- pyrazol-1-yl)propanenitrile::US11578061, Example 32
SMILES CN[C@H]1CC[C@H](COc2ccnc(Nc3cn(nc3C)C(C)(C)C#N)n2)CC1
InChI Key InChIKey=RTBHKWJWDPQWGY-WKILWMFISA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 593054
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [970-2527](Human)
Halia Therapeutics
US Patent
Halia Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:LRRKtide substrate (peptide sequence RLGRDKYKTLRQIRQ, derived from human ezrin [amino acids 561-573], moesin [amino acids 539-553] and radixin [amino...More data for this Ligand-Target Pair